FDA inspection
BioTissue Holdings Inc: FDA inspection ending Feb 18, 2026
FDA inspection 1304322 · Voluntary Action Indicated (VAI) · Doral, FL
Key facts
| Inspection ID | 1304322 |
|---|---|
| Firm | BioTissue Holdings Inc |
| FEI number | 3009809074 |
| Address | 8305 Nw 27th St Ste 101 |
| City | Doral |
| State | FL |
| ZIP | 33122 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Feb 18, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data